US$ 20.92
glp-1 agonists for obesity Comparing Ozempic, Wegovy and Other Drugs What is the pipeline for
Description
Drink sufficient fluids

Sign up for free today.

Westerterp-Plantenga, M
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Analysts project oral drugs could represent approximately 20% of the estimated $80 billion GLP-1 obesity market by 2030 [47]

It is estimated that about 415 million people had diabetes in 2015, and this number may continue to rise to 642 million by 2040

The GLP-1 travels to different parts of our body, like the pancreas and brain, to do its job
